Intellia Therapeutics Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress

Go back to Intellia Therapeutics Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress
(NASDAQ: NTLA) Delayed: 12.14 --0 (-0%)
Previous Close $12.14    52 Week High $30.40 
Open $12.14    52 Week Low $11.86 
Day High $12.14    P/E N/A 
Day Low $12.14    EPS $0.00 
Volume 51,870